As momentum builds at the national level, it's time to prepare for psychedelic therapies!
Due to the high level of interest in this topic, this webinar will be open to non‑members as a one‑time courtesy pass. Register then share this opportunity with your network today!
Up to six travel scholarships will be awarded but the deadline to apply is 2 days away!
Travel scholarship applications and instructions to attend our 42nd Annual Conference on October 26-29, 2026 in Portland, Maine are now available at https://t.co/fP97KZfKUz
The Resolutions/Bylaws Committee is seeking input from members on potential resolutions for consideration at the business meeting that will take place at the 42nd Annual Conference.
Learn more: https://t.co/2Clll4xTZN
Breaking 🚨U. S. Drug Czar Vows to Clean Up Sports, Targets Doping:
@SaraCarterDC calls on World’s athletes and antidoping stakeholders to protect the integrity of drug testing and LA28 Olympics.
https://t.co/g9lKVgFoG5
#LA28#Olympics@wada_ama@drugczar47
Don’t miss this essential briefing on one of the most consequential treatment frontiers in modern medicine!
Explore patient perspectives, clinical research trends, and the regulatory considerations that will shape how these treatments are integrated into care.
Register today!
Our annual conference brings together professionals from across the country who are committed to advancing prevention, treatment, recovery, and enforcement. We hope to see you October 26-29 in Portland, Maine!
Travel scholarships and info are available at https://t.co/fP97KZgiK7
With the President’s recent executive order accelerating federal action on psychedelics, states are facing a rapidly shifting landscape.
Due to the high level of interest in this topic, this webinar will be open to non‑members as a one‑time courtesy pass! https://t.co/CrK3J4ylT3
Takeda is focused on creating better health for people and a brighter future for the world.
With partners like us, Takeda aims to improve the patient experience and advance a new frontier of treatment options through their dynamic and diverse pipeline.
A new Clinical Drug Test Dashboard from @CDCgov could help you find information about substance use disorder (SUD) trends in your area. The dashboard tracks trends in illegal drug use based on data collected from urine drug tests.
Learn more: https://t.co/NukxsG0VKq
@ONDCP Assistant Director @VictorAvilaTX breaks down the new 2026 National Drug Control Strategy and how this plan will directly impact security, stability, and the drug crisis in Mexico and Colombia. ( English and Spanish versions)
https://t.co/HXDabhxjSZ
Another batch of photos from this week's #NABP2026 meeting - Katrina Howard from the Minnesota Board of Pharmacy and Monai Lowe, ED from the District of Columbia Board of Pharmacy. It's like old home week!
It's great to see so many of our members at this week's #NABP2026 conference in Boston including Doug Skvarla from the Arizona Board of Pharmacy and Gretchen Schaub from Definium Therapeutics. Come by our exhibit table sometime today!
Day 2 #NABP2026 conference in Boston starts shortly. Looking forward to seeing everyone. Look who we ran into yesterday? Our @nabp friends Andrew Funk and Neal Watson.
Attending the #NABP2026 Annual Conference in Boston which kicked off today. Great to see so many friends/colleagues including our Board President Eric Griffin from the Ohio Board of Pharmacy and our Secretary/Treasurer Melissa DeNoon from the South Dakota Board of Pharmacy.
The ONDCP Emerging Threats Committee, recently released this new ONDCP Drug Threat Notice on Cychlorphine.
Stay informed about potential or active emerging or evolving drug threats by following @ONDCP !